These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 7933704

  • 1. Effect of MK-507 on aqueous humor dynamics in normal human eyes.
    Yamazaki Y, Miyamoto S, Sawa M.
    Jpn J Ophthalmol; 1994; 38(1):92-6. PubMed ID: 7933704
    [Abstract] [Full Text] [Related]

  • 2. [Effect of topical carbonic anhydrase inhibitor (MK-507) on intraocular pressure of normal human eyes].
    Yamazaki Y, Miyamoto S, Sawa M.
    Nippon Ganka Gakkai Zasshi; 1994 Mar; 98(3):293-7. PubMed ID: 8154389
    [Abstract] [Full Text] [Related]

  • 3. [The time required topical carbonic anhydrase inhibitor (MK-507) to take effect on intraocular pressure of normal human eyes].
    Nakagami T, Yamazaki Y, Miyamoto S, Sawa M.
    Nippon Ganka Gakkai Zasshi; 1995 Sep; 99(9):1022-5. PubMed ID: 7484502
    [Abstract] [Full Text] [Related]

  • 4. A comparison between the effect of topical and systemic carbonic anhydrase inhibitors on aqueous humor secretion.
    Brechue WF, Maren TH.
    Exp Eye Res; 1993 Jul; 57(1):67-78. PubMed ID: 8405174
    [Abstract] [Full Text] [Related]

  • 5. Time course of changes in aqueous protein concentration and flow rate after oral acetazolamide.
    Oshika T, Araie M.
    Invest Ophthalmol Vis Sci; 1990 Mar 01; 31(3):527-34. PubMed ID: 2318591
    [Abstract] [Full Text] [Related]

  • 6. The effect of dorzolamide on aqueous humor dynamics in normal human subjects during sleep.
    Vanlandingham BD, Maus TL, Brubaker RF.
    Ophthalmology; 1998 Aug 01; 105(8):1537-40. PubMed ID: 9709770
    [Abstract] [Full Text] [Related]

  • 7. Combination of systemic acetazolamide and topical dorzolamide in reducing intraocular pressure and aqueous humor formation.
    Rosenberg LF, Krupin T, Tang LQ, Hong PH, Ruderman JM.
    Ophthalmology; 1998 Jan 01; 105(1):88-92; discussion 92-3. PubMed ID: 9442783
    [Abstract] [Full Text] [Related]

  • 8. Population pharmacokinetics of 2% topical dorzolamide in the aqueous humor of humans.
    Schmitz K, Banditt P, Motschmann M, Meyer FP, Behrens-Baumann W.
    Invest Ophthalmol Vis Sci; 1999 Jun 01; 40(7):1621-4. PubMed ID: 10359348
    [Abstract] [Full Text] [Related]

  • 9. Study of the extent of ocular absorption of acetazolamide from a developed niosomal formulation, by microdialysis sampling of aqueous humor.
    Aggarwal D, Pal D, Mitra AK, Kaur IP.
    Int J Pharm; 2007 Jun 29; 338(1-2):21-6. PubMed ID: 17300885
    [Abstract] [Full Text] [Related]

  • 10. Topical carbonic anhydrase inhibitors: a new perspective in glaucoma therapy.
    Hiett JA, Dockter CA.
    Optom Clin; 1992 Jun 29; 2(4):97-112. PubMed ID: 1286242
    [Abstract] [Full Text] [Related]

  • 11. Medical control of intraocular pressure after phacoemulsification.
    Dayanir V, Ozcura F, Kir E, Topaloğlu A, Ozkan SB, Aktunç T.
    J Cataract Refract Surg; 2005 Mar 29; 31(3):484-8. PubMed ID: 15811735
    [Abstract] [Full Text] [Related]

  • 12. Effect of 15-keto latanoprost on intraocular pressure and aqueous humor dynamics in monkey eyes.
    Wang RF, Gagliuso DJ, Mittag TW, Podos SM.
    Invest Ophthalmol Vis Sci; 2007 Sep 29; 48(9):4143-7. PubMed ID: 17724199
    [Abstract] [Full Text] [Related]

  • 13. Regulation of intraocular pressure after water drinking.
    Brucculeri M, Hammel T, Harris A, Malinovsky V, Martin B.
    J Glaucoma; 1999 Apr 29; 8(2):111-6. PubMed ID: 10209727
    [Abstract] [Full Text] [Related]

  • 14. Comparison of dorzolamide and acetazolamide as suppressors of aqueous humor flow in humans.
    Maus TL, Larsson LI, McLaren JW, Brubaker RF.
    Arch Ophthalmol; 1997 Jan 29; 115(1):45-9. PubMed ID: 9006424
    [Abstract] [Full Text] [Related]

  • 15. L-662,583 is a topically effective ocular hypotensive carbonic anhydrase inhibitor in experimental animals.
    Sugrue MF, Gautheron P, Mallorga P, Nolan TE, Graham SL, Schwam H, Shepard KL, Smith RL.
    Br J Pharmacol; 1990 Jan 29; 99(1):59-64. PubMed ID: 2110013
    [Abstract] [Full Text] [Related]

  • 16. Trusopt, a topical carbonic anhydrase inhibitor.
    Donohue EK, Wilensky JT.
    J Glaucoma; 1996 Feb 29; 5(1):68-74. PubMed ID: 8795737
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics, acid-base balance and intraocular pressure effects of ethyloxaloylazolamide--a novel topically active carbonic anhydrase inhibitor.
    Sharir M, Pierce WM, Chen D, Zimmerman TJ.
    Exp Eye Res; 1994 Jan 29; 58(1):107-16. PubMed ID: 8157096
    [Abstract] [Full Text] [Related]

  • 18. Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring?
    Scozzafava A, Menabuoni L, Mincione F, Briganti F, Mincione G, Supuran CT.
    J Med Chem; 1999 Jul 15; 42(14):2641-50. PubMed ID: 10411484
    [Abstract] [Full Text] [Related]

  • 19. Effect of flunarizine, a calcium channel blocker, on intraocular pressure and aqueous humor dynamics in monkeys.
    Wang RF, Gagliuso DJ, Podos SM.
    J Glaucoma; 2008 Jul 15; 17(1):73-8. PubMed ID: 18303390
    [Abstract] [Full Text] [Related]

  • 20. The effects of carbonic anhydrase inhibitors on aqueous humor chemistry and dynamics.
    Bar-Ilan A, Pessah NI, Maren TH.
    Invest Ophthalmol Vis Sci; 1984 Oct 15; 25(10):1198-205. PubMed ID: 6434487
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.